Biogenic Amines and Emotion

Abstract

The studies discussed here have shown a fairly consistent relationship between the effects of drugs on biogenic amines, particularly norepinephrine, and affective or behavioral states. Those drugs which cause depletion and inactivation of norepinephrine centrally produce sedation or depression, while drugs which increase or potentiate brain norepinephrine are associated with behavioral stimulation or excitement and generally have an antidepressant effect in man (Table 1). From these findings, a number of investigators have formulated the concept, designated the catecholamine hypothesis of affective disorders (6), that some, if not all, depressions may be associated with a relative deficiency of norepinephrine at functionally important adrenergic receptor sites in the brain, whereas elations may be associated with an excess of such amines. It is not possible either to confirm or to reject this hypothesis on the basis of currently available clinical data. Although there does appear to be a fairly consistent relationship between the effects of pharmacological agents on norepinephrine metabolism and on affective state, a rigorous extrapolation from pharmacological studies to pathophysiology cannot be made. Confirmation of this hypothesis must ultimately depend upon direct demonstration of the biochemical abnormality in the naturally occurring illness. It should be emphasized, however, that the demonstration of such a biochemical abnormality would not necessarily imply a genetic or constitutional, rather than an environmental or psychological, etiology of depression. Whereas specific genetic factors may be of importance in the etiology of some, and possibly all, depressions, it is equally conceivable that early experiences of the infant or child may cause enduring biochemical changes and that these may predispose some individuals to depressions in adulthood. It is not likely that changes in the metabolism of the biogenic amines alone will account for the complex phenomena of normal or pathological affect. Whereas the effects of these amines at particular sites in the brain may be of crucial importance in the regulation of affect, any comprehensive formulation of the physiology of affective state will have to include many other concomitant biochemical, physiological, and psychological factors. Although in this review of the relationship of biogenic amines to affective state relatively little has been said concerning the intricate set of environmental and psychological determinants of emotion, the importance of these factors must be stressed. The normally occurring alterations in affective state induced by environmental events is well known to all, from personal experience. The interactions between such environmental determinants of affect, various physiological factors, and the complexity of psychological determinants, including cognitive factors derived from the individual's remote and immediate past experiences, have received only limited study under adequately controlled conditions. It may be anticipated, however, t...

Effects of intraventricular 2,4,5‐trihydroxyphenylethylamine (6‐hydroxydopamine) on rat behaviour and brain catecholamine metabolism

“…This result was consistent with the hypo-6-Hydroxydopamine on rat behaviour thesis that 6HD produces a selective acute degeneration of NA-containing nerve terminals in the brain similar to that produced in the peripheral sympathetic system (Tranzer & Thoenen, 1968;Malmfors & Sachs, 1968). However, despite the large doses of 6HD administered, behavioural changes which might be expected after the acute destruction of central noradrenergic neurones (Schildkraut & Kety, 1967) were not reported.…”

Impact of Lead Toxicity on Brain Metabolisms of Nucleic Acid and Catecholamine in Protein Malnourished Rats.

“…Lead-treated mice were also shown to exhibit hyperac tivity (11). On the other hand, behavioral stimulation or excitation in a number of situations was found to be associated with increased brain levels of NE and DA (46). Accordingly, the increased levels of NE and DA contents of brain following lead treatment, as noted in the present investigation, are in conformity with the above observations.…”

Mechanistic Role for a Novel Glucocorticoid-KLF11 (TIEG2) Protein Pathway in Stress-induced Monoamine Oxidase A Expression

“…MAO A primarily deaminates serotonin, norepinephrine, and dopamine and, therefore, is implicated in several psychiatric diseases. Elevated brain MAO A levels are present in living patients and post-mortem human subjects with depressive disorders, including major depressive disorder (8 -12) and in mothers during postpartum depression (13), supporting the theory that an imbalance in biogenic amines can influence the affective state (14,15). Such correlations suggest MAO A to be a biochemical link for stress and depression, which often exists comorbidly in clinical studies.…”